What does APOTHEEK QUEENS do?

APOTHEEK QUEENS is a logistics company in Turnhout. Private Limited, started on 13 October 2005, 1 establishment.

What is the address of APOTHEEK QUEENS?

The registered office of APOTHEEK QUEENS is located at Steenweg op Antwerpen 31 box 3, 2300 Turnhout.

Is APOTHEEK QUEENS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK QUEENS is active, legal situation “Normale toestand”, started on 13 October 2005.

Is APOTHEEK QUEENS registered on Peppol?

Yes, APOTHEEK QUEENS is registered on the Peppol network with ID 0208:0876665709.

What is the enterprise number of APOTHEEK QUEENS?

The enterprise number of APOTHEEK QUEENS is BE0876665709.

When was APOTHEEK QUEENS founded?

APOTHEEK QUEENS was founded on 13 October 2005.

Who are the directors of APOTHEEK QUEENS?

According to the 2025 annual accounts, the directors of APOTHEEK QUEENS are: Boone-Gielen Invest NV.

Is APOTHEEK QUEENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 October 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK QUEENS make in 2025?

APOTHEEK QUEENS recorded a loss after taxes of € 9,737 in financial year 2025.

What is the revenue of APOTHEEK QUEENS?

As a small company, APOTHEEK QUEENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 225,942.

How much does an employee at APOTHEEK QUEENS earn?

The average wage cost per full-time employee at APOTHEEK QUEENS was € 84,400 in 2025: staff costs of € 211,057 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK QUEENS have?

According to the 2025 annual accounts, APOTHEEK QUEENS has 2.5 full-time equivalents (FTE).

APOTHEEK QUEENS (Private Limited) - Turnhout

Dossier APOTHEEK QUEENS, printed on 30 October 2026 from databakkes.be/en/0876665709/apotheek-queens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK QUEENS from Turnhout, company number BE0876665709, closed financial year 2025 with a result of € -9,737 after tax. For that financial year APOTHEEK QUEENS recorded a gross margin of € 225,942 and equity of € 311,199. Compared with financial year 2024, the result moved from € 34,071 to € -9,737. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What it is worth Healthy

€ 311,199

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9,737

▼ still € 34,071 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 96,241

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 292,599.

People and assets in 2025

Full-time equivalents

2.5

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 211,057

▲ 43% vs 2024

€ 84,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,827

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 200,000

▼ 11% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 76,319

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,695

▲ 71% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 189,757 Gross margin 2022: € 189,757 First fiscal year in the series	€ 207,610 Gross margin 2023: € 207,610 ▲ 9% vs 2022 (€ 189,757) Favourable step	€ 225,215 Gross margin 2024: € 225,215 ▲ 8% vs 2023 (€ 207,610) Favourable step	€ 225,942 Gross margin 2025: € 225,942 Unchanged (€ 225,215) Favourable step
Profit after taxes	€ 24,656 Profit after taxes 2022: € 24,656 First fiscal year in the series	€ 27,863 Profit after taxes 2023: € 27,863 ▲ 13% vs 2022 (€ 24,656) Favourable step	€ 34,071 Profit after taxes 2024: € 34,071 ▲ 22% vs 2023 (€ 27,863) Favourable step	€ -9,737 Profit after taxes 2025: € -9,737 ▼ € 43,808 vs 2024 (€ 34,071) Unfavourable step	▼ € 43,808
Equity	€ 255,816 Equity 2022: € 255,816 First fiscal year in the series	€ 283,680 Equity 2023: € 283,680 ▲ 11% vs 2022 (€ 255,816) Favourable step	€ 317,750 Equity 2024: € 317,750 ▲ 12% vs 2023 (€ 283,680) Favourable step	€ 311,199 Equity 2025: € 311,199 ▼ 2% vs 2024 (€ 317,750) Unfavourable step	▼ 2%
Total debts	€ 379,609 Total debts 2022: € 379,609 First fiscal year in the series	€ 366,237 Total debts 2023: € 366,237 ▼ 4% vs 2022 (€ 379,609) Favourable step	€ 328,781 Total debts 2024: € 328,781 ▼ 10% vs 2023 (€ 366,237) Favourable step	€ 302,453 Total debts 2025: € 302,453 ▼ 8% vs 2024 (€ 328,781) Favourable step	▼ 8%
Cash	€ 157,084 Cash 2022: € 157,084 First fiscal year in the series	€ 159,142 Cash 2023: € 159,142 ▲ 1% vs 2022 (€ 157,084) Favourable step	€ 140,920 Cash 2024: € 140,920 ▼ 11% vs 2023 (€ 159,142) Unfavourable step	€ 96,241 Cash 2025: € 96,241 ▼ 32% vs 2024 (€ 140,920) Unfavourable step	▼ 32%
Land & buildings	€ 227,843 Land & buildings 2022: € 227,843 First fiscal year in the series	€ 219,739 Land & buildings 2023: € 219,739 ▼ 4% vs 2022 (€ 227,843) Unchanged	€ 211,636 Land & buildings 2024: € 211,636 ▼ 4% vs 2023 (€ 219,739) Unchanged	€ 205,347 Land & buildings 2025: € 205,347 ▼ 3% vs 2024 (€ 211,636) Unchanged	▼ 3%
Retained profit	€ 237,216 Retained profit 2022: € 237,216 First fiscal year in the series	€ 265,080 Retained profit 2023: € 265,080 ▲ 12% vs 2022 (€ 237,216) Favourable step	€ 299,150 Retained profit 2024: € 299,150 ▲ 13% vs 2023 (€ 265,080) Favourable step	€ 292,599 Retained profit 2025: € 292,599 ▼ 2% vs 2024 (€ 299,150) Unfavourable step	▼ 2%
Bank debt	€ 258,504 Bank debt 2022: € 258,504 First fiscal year in the series	€ 239,002 Bank debt 2023: € 239,002 ▼ 8% vs 2022 (€ 258,504) Favourable step	€ 223,501 Bank debt 2024: € 223,501 ▼ 6% vs 2023 (€ 239,002) Favourable step	€ 200,000 Bank debt 2025: € 200,000 ▼ 11% vs 2024 (€ 223,501) Favourable step	▼ 11%
Balance sheet total	€ 648,879 Balance sheet total 2022: € 648,879 First fiscal year in the series	€ 662,667 Balance sheet total 2023: € 662,667 ▲ 2% vs 2022 (€ 648,879) Unchanged	€ 658,577 Balance sheet total 2024: € 658,577 ▼ 1% vs 2023 (€ 662,667) Unchanged	€ 621,995 Balance sheet total 2025: € 621,995 ▼ 6% vs 2024 (€ 658,577) Unchanged	▼ 6%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▲ 0.8 vs 2024 (1.7) Unchanged	▲ 0.8

Key figures of APOTHEEK QUEENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK QUEENS?

What happened at APOTHEEK QUEENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 18, 2026 New annual accounts for financial year 2025: loss of € 9,737 (▼ € 43,808 vs 2024). filed late Source: NBB ↗
Jan 1, 2006 New establishment in Turnhout. KBO
Oct 13, 2005 Start of the company according to the CBE. KBO

In short

From € 24,656 profit in 2022 to € 9,737 loss in 2025.

Paid € 32,673 in corporate taxes since 2022.

Best year ever: 2024, with € 34,071 profit.

On average € 90,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BOONE-GIELEN INVEST 100%

The stake of BOONE-GIELEN INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK QUEENS

Behind APOTHEEK QUEENS is Boone-Gielen Invest NV. The shares are held by BOONE-GIELEN INVEST (100%).

Directors

According to the 2025 annual accounts

Boone-Gielen Invest NV

Director · represented by Guido Boone

Also active at: APOTHEEK HEALTHCORNER, HUVEFAR, YOBERA, APOTHEEK PUT

Shareholders

BOONE-GIELEN INVEST

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg op Antwerpen 31 box 3

2300 Turnhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SK Accounting

€ 216,680 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0876.665.709

VAT number

BE 0876.665.709

Registered office

Steenweg op Antwerpen 31 bus 3, 2300 Turnhout

Names & denominations

APOTHEEK QUEENS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 October 2005

Peppol

Active · Active since 21 Jan 2026

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK QUEENS

Financials

What happened to APOTHEEK QUEENS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions